Colitis ulcerosa: vizsgálatok itt: Japán
23 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Where
- Fukuoka, Kamakura, Kashiwa, Osaka, Sakura, Sapporo
- Életkor
- 18 év to 80 év
- People
- 252 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07186101 - 2. fázisTaking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Asahikawa, Bunkyō City, Fujiidera, Fukuoka, Hirosaki, Kagoshima, Kashiwa, Mitaka, Niigata, Nishinomiya, Okayama, Saitama, Sapporo, Suita, Tokyo
- Életkor
- 18 év to 80 év
- People
- 1431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Fuchū, Kanazawa, Kobe, Kumamoto, Matsumoto, Saga, Yokohama
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Bunkyō City, Hamamatsu, Higashiharima, Kagoshima, Kashiwa, Kumamoto, Minatoku, Mitaka, Nagakute, Nishinomiya, Ōita, Osaka, Saga, Sapporo, Shimizu, Shinjuku-Ku, Sumida Tokyo, Tokyo, Yamanashi, Yokohama
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - 1/2. fázisTaking peopleSafety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
- Where
- Bunkyo-ku, Fukuoka, Hamamatsu, Hirakata, Kurashiki, Minato-ku, Mitaka, Sapporo
- Életkor
- 18 év to 75 év
- People
- 54 worldwide
- Run by
- Metagen Therapeutics, Inc.
See details and how to joinNCT07913347 - 2. fázisTaking peopleA Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Where
- Bunkyo-ku, Ikoma, Kashiwa, Kyoto, Maebashi, Nagareyama-shi, Nishinomiya, Saga, Saitama-Shi, Shimotsuke, Toyama
- Életkor
- 12 év to 17 év
- People
- 36 worldwide
- Run by
- Pfizer
See details and how to joinNCT05287126 · EU 2022-500345-25-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Fujidera-shi, Fukuoka, Fukuyama-shi, Kanazawa, Kashiwa-shi, Nagoya, Osaka, Saga, Takamatsu
- Életkor
- 18 év and over
- People
- 224 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Bunkyō-Ku, Chikushino-shi, Chuo Ku, Kashiwa, Kobe, Maebashi, Minato-Ku, Nara, Ōita, Okayama, Osaka, Saga, Sakura, Sendai, Shinjuku-Ku, Shiwa-gun, Takatsuki, Tsu, Urayasu-shi, Yokohama
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 3. fázisTaking peopleA Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- Bunkyo-ku, Fuchu-shi, Fukushima, Hamamatsu, Kashiwa-shi, Kobe, Kumamoto, Kurume-shi, Maebashi, Ōbu, Saga, Saitama-shi, Setagaya City
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00 - 2. fázisTaking peopleStudy of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Where
- Kure
- Életkor
- 18 év to 75 év
- People
- 2000 worldwide
- Run by
- AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00 - 2. fázisTaking peopleA Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Where
- Kumamoto, Saitama-Shi, Tokyo
- Életkor
- 2 év to 11 év
- People
- 24 worldwide
- Run by
- Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Asahikawa, Bunkyō City, Chikushino-shi, Chūō, Fukuoka, Kagoshima, Kamakura, Kanazawa, Kashiwa, Kobe, Kumamoto, Nagaoka, Okayama, Osaka, Panevezys, Saga, Sakura, Sapporo, Sendai, Shinjuku, Shiwa-gun, Tokyo, Toyama, Toyohashi, Tsu, Yokohama
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - 2/3. fázisTaking peopleA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Bunkyo-ku, Hiroshima, Komatsu, Kurume-shi, Ōbu, Setagaya-Ku, Shinjuku-ku, Takatsuki, Tokyo, Yokohama
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Bunkyō City, Chikushino-shi, Hachiōji, Kagoshima, Kamakura, Kashiwa, Kobe, Kōriyama, Kumamoto, Minato, Nagaoka, Nishinomiya, Osaka, Saga, Sapporo, Sendai, Takamatsu, Toyama, Toyohashi, Tsu, Yokohama
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - 3. fázisTaking peopleA Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Bunkyo-ku, Kurume-shi, Setagaya-Ku
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00 - 3. fázisTaking peopleA Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Where
- Bunkyō, Bunkyō City, Kashiwa, Kobe, Tokyo, Yokohama
- Életkor
- 2 év to 19 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT04844606 - No phaseTaking peopleStudy to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis
- Where
- Bunkyo-ku, Chiba, Fukuoka, Hamamatsu, Hirakata-shi, Hirosaki, Hiroshima, Kashiwa-shi, Kawagoe, Kobe, Kyoto, Mibu, Minato-ku, Mitaka-shi, Nagakute, Nagoya, Nishinomiya-shi, Okayama, Ōtsu, Saga, Sakura, Sapporo, Sunto-gun, Tokyo, Toyama
- Életkor
- 15 év and over
- People
- 200
- Run by
- AbbVie
See details and how to joinNCT07136116 - No phaseTaking peopleAssociation Between LRG and Histologic Remission in Ulcerative Colitis
- Where
- Komagane
- Életkor
- 20 év to 90 év
- People
- 100
- Run by
- Showa Inan General Hospital
See details and how to joinNCT06372613 - 3. fázisTaking peopleA Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Where
- Bunkyo-ku, Kurume, Setagaya-Ku
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00 - No phaseTaking peopleEfficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
- Where
- Komagane
- People
- 30
- Run by
- Showa Inan General Hospital
See details and how to joinNCT07243639 - No phaseTaking peopleEffectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
- Where
- Asahikawa, Chiba, Chikushino-shi, Fukuoka, Hamamatsu, Hidaka-shi, Hirakata, Hokkaidō, Kashiwa-shi, Matsuyama, Minato-ku, Mitaka-shi, Nishinomiya, Saga, Sakura, Sapporo, Takamatsu, Tottori-shi
- Életkor
- 18 év and over
- People
- 150
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07271069 - 3. fázisTaking peopleA Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Bunkyo-ku, Hidaka, Kumamoto, Kurume-shi, Setagaya-Ku
- Életkor
- 2 év to 17 év
- People
- 240 worldwide
- Run by
- Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00 - No phaseTaking peopleAI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
- Where
- Tokyo
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- University College Cork
See details and how to joinNCT06709209